This Web site and in particular, the Gilead Investor Resources section of the Web site, may contain information considered to be forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflects management's expectations. We remind you that actual results could vary dramatically as a result of known and unknown risks and uncertainties, including but not limited to: potential issues related to financial situation, competition, the ability to retain key personnel, product acceptance, the commercial success of any new products or technologies, success of clinical programs, ability to retain key customers, inability to expand sales and channels, legislation or regulations affecting product pricing, reimbursement or access, the ability to protect our patents and other intellectual property both domestically and internationally and other known and unknown risks and uncertainties. You are cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s most recently filed Annual Reports on Form 10-K and in Gilead's Quarterly Reports on Form 10-Q, all of which are on file with the U.S. Securities and Exchange Commission.

Gilead press releases are archived on this Web site for historical purposes only. Information contained in such releases is accurate at the time of release. Specific information included in these releases may change over time, and may or may not be accurate after the date on the release. Gilead has no intention and specifically disclaims any duty to update the information in these historical press releases.

NASDAQ (US Dollar)
$83.20
 Stock is Up 0.93 (1.13%)
Data as of 06/30/16 3:07 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at William Blair & Company's 2016 Growth Stock Conference

June 14, 2016 8:10 a.m. CT
Play
Gilead Sciences at Jefferies 2016 Healthcare Conference

June 10, 2016 10:30 a.m. ET
Play